Instead, the forward-looking statements contained in this communication are based on our current expectations, assumptions and beliefs concerning future developments and their potential effects on us
doi:10.1042/BSR20181061 175
Unlike the clinics and medical spas targeted by Novo, Hims does reveal that the drugs it sells are not FDA approved but in one ad seen by a Hunterbrook Media reporter, it does so only in barely visible font that blends into the background of its ads
Research shows that people who stop a GLP-1 after losing weight often regain weight within a year
Three cases occurred across 1,032 total trial participants
Notably, participants had not reached a weight loss plateau by the end of the 48-week study, suggesting that the full weight loss potential of retatrutide may extend beyond this timeframe